Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

NCT06017284 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06017284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06017284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer
Lead sponsor
Fudan University
Phase
Phase 3
Overall status
Recruiting
Start date
November 1, 2023
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced nausea and vomiting, pancreatic cancer stage iv